Cosmo Pharmaceuticals NV
SIX:COPN
Wall Street
Price Targets
COPN Price Targets Summary
Cosmo Pharmaceuticals NV
According to Wall Street analysts, the average 1-year price target for
COPN
is 130.56 CHF
with a low forecast of 103.02 CHF and a high forecast of 157.5 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is COPN's stock price target?
Price Target
130.56
CHF
According to Wall Street analysts, the average 1-year price target for
COPN
is 130.56 CHF
with a low forecast of 103.02 CHF and a high forecast of 157.5 CHF.
What is Cosmo Pharmaceuticals NV's Revenue forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Cosmo Pharmaceuticals NV's revenue is
17%.
The projected
CAGR
for the next 4 years is
6%.
What is Cosmo Pharmaceuticals NV's Operating Income forecast?
Projected CAGR
4%
For the last 13 years the
compound annual growth rate for
Cosmo Pharmaceuticals NV's operating income is
24%.
The projected
CAGR
for the next 4 years is
4%.
What is Cosmo Pharmaceuticals NV's Net Income forecast?
Projected CAGR
4%
For the last 13 years the
compound annual growth rate for
Cosmo Pharmaceuticals NV's net income is
25%.
The projected
CAGR
for the next 4 years is
4%.
